Bio

Bio


Dr. Alyssa Burgart is a board certified anesthesiologist, specializing in pediatric anesthesia. She has special interest in abdominal transplantation, regional anesthesia, and trauma. Dr. Burgart is committed to finding the most successful way for each child to interact with the anesthesia team, in order to create an overall positive experience.

Dr. Burgart has a joint appointment in the Stanford Center for Biomedical Ethics, serves as the Co-Chair of the LPCH Ethics Committee and as a member of the SHC Ethics Committee. Her interests include research on the practice of medicine, organ transplantation, end-of-life care, ethics education, and ethics consultation.

Clinical Focus


  • Anesthesia
  • Bioethics
  • Pediatric Anesthesia
  • Anesthesia for Liver Transplant

Academic Appointments


Administrative Appointments


  • Co-Chair, Lucile Packard Children's Hospital Ethics Committee (2016 - Present)
  • Member, Lucile Packard Children's Hospital Ethics Committee (2015 - Present)
  • Member, Stanford Hospital and Clinics Ethics Committee (2015 - Present)

Professional Education


  • Board Certification: Anesthesia, American Board of Anesthesiology (2015)
  • Fellowship:Lucile Packard Children's Hospital (2015) CA
  • Residency:Loyola University Medical Center (2014) IL
  • Internship:Loyola University Medical Center (2011) IL
  • MA, Loyola University Chicago, Bioethics and Health Policy (2010)
  • Medical Education:Loyola University Stritch School of Medicine (2010) IL
  • BA, University of Judaism, Bioethics (2003)

Publications

All Publications


  • Randomized n-of-1 Trials: Quality Improvement, Research, or Both? Pediatrics Samuel, J. P., Burgart, A., Wootton, S. H., Magnus, D., Lantos, J. D., Tyson, J. E. 2016; 138 (2)

    Abstract

    The regulatory demarcations between clinical research and quality improvement (QI) are ambiguous and controversial. Some projects that were undertaken as a form of QI were deemed by regulatory agencies to be research and thus to require institutional review board approval. In the era of personalized medicine, some physicians may ask some patients to participate in n-of-1 trials in an effort to personalize and optimize each patient's medical treatment. Should such activities be considered research, QI, or just excellent personalized medicine? Experts in research, research regulation, and bioethics analyze these issues.

    View details for DOI 10.1542/peds.2016-1103

    View details for PubMedID 27385811